Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 55.53
-1.55 (-2.72%)
Apr 29, 2026, 3:04 PM CST
SHE:002653 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 259.58 | 395.46 | 295.11 | 277.07 | 345.06 | Upgrade
|
| Depreciation & Amortization | 273.5 | 249.22 | 219.58 | 184.12 | 153.19 | Upgrade
|
| Other Amortization | 9.88 | 5.47 | 2.91 | 4.29 | 3.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | 22.27 | -31.1 | 0.28 | 0 | 0.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.36 | 83.19 | 13.02 | 0.84 | 0.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | 17.15 | -117.39 | 60.47 | -227.72 | -420.77 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.42 | 1.79 | 0.3 | 0.91 | 0.32 | Upgrade
|
| Other Operating Activities | 32.41 | 109.61 | 42.13 | 167.43 | 202.79 | Upgrade
|
| Change in Accounts Receivable | 139.81 | -182.98 | -70.94 | -191.11 | -45.88 | Upgrade
|
| Change in Inventory | -35.93 | 10.82 | 66.19 | -90.38 | -36.29 | Upgrade
|
| Change in Accounts Payable | -52.06 | -82.55 | -352.48 | -4.41 | -264.99 | Upgrade
|
| Change in Other Net Operating Assets | 130.08 | 29.75 | 193.51 | 14.82 | 101.71 | Upgrade
|
| Operating Cash Flow | 786 | 442.05 | 449.58 | 94.55 | 35.8 | Upgrade
|
| Operating Cash Flow Growth | 77.81% | -1.68% | 375.51% | 164.08% | -82.64% | Upgrade
|
| Capital Expenditures | -331.98 | -440.65 | -391.01 | -700.17 | -702.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 13.45 | 31.42 | 4.29 | 0.36 | 0.33 | Upgrade
|
| Divestitures | 0.3 | - | - | - | 180.16 | Upgrade
|
| Investment in Securities | 151.18 | 10.82 | 0.34 | 159.62 | 781.92 | Upgrade
|
| Other Investing Activities | 11.07 | 96.81 | 3.19 | 0.3 | 22.5 | Upgrade
|
| Investing Cash Flow | -155.98 | -301.61 | -383.19 | -539.88 | 281.97 | Upgrade
|
| Long-Term Debt Issued | 1,059 | 1,400 | 898.36 | 2,000 | 932.21 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -2.26 | Upgrade
|
| Long-Term Debt Repaid | -1,017 | -1,309 | -1,206 | -1,153 | -816.65 | Upgrade
|
| Total Debt Repaid | -1,017 | -1,309 | -1,206 | -1,153 | -818.91 | Upgrade
|
| Net Debt Issued (Repaid) | 41.35 | 90.38 | -307.16 | 847.22 | 113.3 | Upgrade
|
| Issuance of Common Stock | - | 80.94 | 793.64 | - | 23.76 | Upgrade
|
| Repurchase of Common Stock | - | - | -8.16 | -6.37 | -2.47 | Upgrade
|
| Common Dividends Paid | -333.15 | -422.04 | -42.57 | -247.49 | -426.21 | Upgrade
|
| Other Financing Activities | -0.39 | 0.05 | -107.68 | 30.87 | 104.38 | Upgrade
|
| Financing Cash Flow | -292.18 | -250.68 | 328.07 | 624.23 | -187.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.86 | 4.87 | -1.54 | 16.94 | -6.77 | Upgrade
|
| Net Cash Flow | 330.99 | -105.37 | 392.92 | 195.84 | 123.77 | Upgrade
|
| Free Cash Flow | 454.03 | 1.39 | 58.57 | -605.62 | -667.14 | Upgrade
|
| Free Cash Flow Growth | 32537.74% | -97.63% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 10.35% | 0.04% | 1.75% | -20.09% | -24.06% | Upgrade
|
| Free Cash Flow Per Share | 0.40 | 0.00 | 0.05 | -0.57 | -0.62 | Upgrade
|
| Cash Income Tax Paid | 382.37 | 414.04 | 329.11 | 197.09 | 173.38 | Upgrade
|
| Levered Free Cash Flow | 196.77 | -209.72 | -152.29 | -781.91 | -895.41 | Upgrade
|
| Unlevered Free Cash Flow | 217.1 | -186.08 | -125.87 | -750.09 | -878.44 | Upgrade
|
| Change in Working Capital | 160.28 | -254.19 | -184.24 | -312.4 | -248.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.